AB vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 14, 2026

AB

40.8
AI Score
VS
AB Wins

FHI

36.3
AI Score

Investment Advisor Scores

AB

41score
Recommendation
HOLD

FHI

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric AB FHI Winner
Forward P/E 8.8496 10.7759 AB
PEG Ratio 0.6343 1.5181 AB
Revenue Growth -40.3% 8.1% FHI
Earnings Growth -0.7% 11.9% FHI
Tradestie Score 40.8/100 36.3/100 AB
Profit Margin 0.0% 21.3% FHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY AB

Relative Price Performance (Last 90 Days)

AB 1M: -3.7% · 3M: -7.5% FHI 1M: +12.9% · 3M: -0.6%

Current Technical Phase

AB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 33

RSI (14): 33.2 · Price: $33.49

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.1 · Price: $63.76

Fundamentals Snapshot

Metric AB FHI
Market Cap — —
Forward P/E 9.1 10.7
Trailing P/E 10.0 11.5
Revenue (TTM) — —
Revenue Growth -0.4% 0.1%
Gross Margin 1.0% 0.7%
Operating Margin 0.0% 0.3%
EPS 3.37 5.53
Dividend Yield 0.10% 0.02%

Frequently Asked Questions

Based on our detailed analysis, AB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.